Product Images Everolimus

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Everolimus NDC 63850-0062 by Natco Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

everolimus 0 25mg bottle label

everolimus 0 25mg bottle label

carton - everolimus 0 25mg carton

carton - everolimus 0 25mg carton

This is a package insert for Everolimus tablets manufactured by Natco Pharma Limited in India. The tablets contain 0.25mg of the drug and the dosage information can be found in the insert. It is important to keep this medication away from children and to store it at temperatures between 15°C-30°C (59°F-86°F). The medication should also be protected from light and moisture. Side effects should be reported to a doctor or to the FDA.*

foil - everolimus 0 25mg foil

foil - everolimus 0 25mg foil

This is a list of medications containing Everolimus Tablets of 0.25mg and 0.26mg. These tablets are manufactured by Natco Pharma Ltd and are used to treat certain types of cancer. The batch numbers and expiry dates of the tablets are also provided for reference.*

everolimus 0 5mg bottle label

everolimus 0 5mg bottle label

carton - everolimus 0 5mg carton

carton - everolimus 0 5mg carton

This is a package insert for Everolimus tablets in a dosage of 0.5mg per tablet. It includes a warning to keep the medication out of children's reach, instructions for storage temperatures, and a reminder to call a doctor if experiencing side effects. The manufacturer is Natco Pharma Limited in India, and the tablets come in a carton of 60 tablets, with 6 blister cards of 10 tablets each. The NDC number for this medication is 63850-0063-2.*

foil - everolimus 0 5mg foil

foil - everolimus 0 5mg foil

This text seems to be a list of details about the Everolimus Tablet, 0.5 mg, manufactured by Natco Pharma Ltd., which includes information like the HDC code, NDC code, date of issue, and batch number. However, some of the text is unreadable due to being cut off or unrecognized characters, so it is difficult to determine the complete information.*

everolimus 0 75mg bottle label

everolimus 0 75mg bottle label

carton - everolimus 0 75mg carton

carton - everolimus 0 75mg carton

The text is a medication label for Everolimus Tablets, manufactured by Natco Pharma Limited in India. The recommended dosage is provided in the package insert, and it is advised to keep the medication out of the reach of children and protected from light and moisture. The tablets contain 0.75 mg per tablet and are packed in a carton with six individual blister cards of ten tablets each. The NDC number for the tablets is 63850-0064-2. Patients should call their doctor for medical advice about side effects and can report side effects to FDA at 1-800-FDA-1088.*

foil - everolimus 0 75mg foil

foil - everolimus 0 75mg foil

This is a list of several pharmaceutical products identified by their National Drug Codes (NDCs) and manufacturers. The products are Evarolimus and Everolimus Tablets, which come in different strengths (0.75 mg and 0.76 mg). The manufacturers are Nateo Pharma Ltd. and Natco Pharma Ltd. The products have different lot numbers, and some of them come with expiration dates. There is no further information about these pharmaceutical products.*

everolimus-fig-1 - everolimus fig 1

everolimus-fig-1 - everolimus fig 1

This is a table showing the €GFR (MDRD 4) values in mL/min/1.73m^2 for different visit windows and treatment groups. The treatment groups include EVR+Reduced TAC, A&~ TAC, and TAC Control. The values range from 60 to 110 mL/min/1.73m^2.*

everolimus chemical structure - everolimus structure

everolimus chemical structure - everolimus structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.